CJC-1295 might also be linked with the purported drug affinity complex (DAC) element, which may attach to plasma proteins
Novel cytoprotective mediator, stable gastric pentadecapeptide BPC 157
[PubMed: 27005575] 34
In preclinical and in vitro applications, it is used for the study of such factors as cellular proliferation, modulation of protein synthesis, glucose uptake, differentiation among adipocyte muscle precursor cells, as well as DNA synthesis
Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes
CJC-1295/Ipamorelin is the most popular protocol because the dual pathway produces broader effects (recovery, sleep, body composition) and the cost is lower than Tesamorelin